Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Zim Laboratories
|
Albert David
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-23.88 % | 7.41 % | 11.47 % |
|
5yr Avg Net Profit Margin
|
-23.79 % | 4.15 % | 11.31 % |
|
Price to Book
|
4.17 | 1.44 | 1.18 |
|
P/E
|
0.0 | 38.71 | 73.9 |
|
5yr Avg Cash Conversion Cycle
|
-10.34 Days | 37.07 Days | -77.77 Days |
|
5yr Average Interest Coverage Ratio
|
-11.84 | 3.96 | 93.73 |
|
5yr Avg ROCE
|
-15.03 % | 13.52 % | 14.69 % |
|
5yr Avg Operating Profit Margin
|
-13.23 % | 12.21 % | 9.55 % |
|
5 yr average Debt to Equity
|
0.21 | 0.39 | 0.02 |
|
5yr CAGR Net Profit
|
0.22 % | 10.7 % | -4.92 % |
|
5yr Average Return on Assets
|
-14.62 % | 4.02 % | 7.03 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 33.26 % | 62.24 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | 0.0 | 0.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | 0.0 |
|
Brooks Laboratories
|
Zim Laboratories
|
Albert David
|
|---|